Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|November 4, 2025
Neoadjuvant endocrine therapy often leads to breast and axilla-conserving surgery in stages II and III hormone receptor-positive breast cancer patients: A registry studyLayla Andour, Judith R Kroep, Hein Putter, et al.
Breast Cancer Research and Treatment|January 24, 2024
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?Merel E van de Loo, Layla Andour, Anne E van Heesewijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtypeClaudette E Loo, Marieke E Straver, Sjoerd Rodenhuis, et al.
American Journal of Surgery|December 20, 2008
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapyMarieke E Straver, Emiel J T Rutgers, Hester S A Oldenburg, et al.
Annals of Surgery|March 13, 2010
MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapyMarieke E Straver, Claudette E Loo, Emiel J T Rutgers, et al.
International Journal of Cancer|April 11, 2026
The Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast CancerLayla Andour, Sophie C Hagenaars, Anne Florine de Groot, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2010
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancerTjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsMarieke E Straver, Tjeerd S Aukema, Renato A Valdes Olmos, et al.
Breast Cancer Research and Treatment|August 12, 2009
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseJorma J de Ronde, Juliane Hannemann, Hans Halfwerk, et al.
Annals of Surgery|April 19, 2014
Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedureMila Donker, Marieke E Straver, Jelle Wesseling, et al.
Pageof 3